Health technology company using non-invasive disease screenings to treat diseases.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
Freenome is a health technology company using accurate, accessible and non-invasive disease screenings to proactively treat cancer and other diseases at their most manageable stages. Freenome does this through a fusion of machine learning, biology and computer science.
Freenome Funding
Sign up to gain insights into Freenome funding history, including the funding round, time period, and amount raised.
| Financing Round | Date | Amount | Price per share | Valuation |
|---|---|---|---|---|
| Round | Date | Amount | PPS | Valuation |
| Series F | Feb 15, 2024 | 254M | ||
| Series E | Jan 11, 2022 | 290M | ||
| Series D | Nov 22, 2021 | 243M | ||
| Series C | Aug 14, 2020 | 270M | ||
| Series B | Jun 24, 2019 | 160M | ||
| Series A | Aug 14, 2017 | 8M | ||
| Series A | Feb 23, 2017 | 64M | ||
| Series Seed | May 23, 2016 | 6M |
Access the PPS, Valuation details, and a wealth of other data by signing up. Source: Nasdaq Private Market
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Freenome Management Team
Investors
Charles River Ventures (CRV)
T. Rowe Price
Catalio Capital Management
Novartis
Founders Fund
Section 32
Soleus Capital Management
Cormorant Capital
Rock Springs Capital
Data Collective
EcoR1 Capital
Janus Henderson
Kaiser Permanente Ventures
F. Hoffmann-La Roche
Bain Capital
Polaris Partners
Artis Ventures
Farallon Capital Management
RA Capital Management
Asset Management Ventures
Spectrum 28 Capital
Innovation Endeavors
BrightEdge
Verily Life Sciences
Fidelity
Perceptive Advisors
Sands Capital Management
Roche Venture Fund
Colorectal Cancer Alliance
Third Kind Venture Capital
Cormorant Asset Management
Ridgeback Capital
DCVC
Andreessen Horowitz
Freenome Valuations & Financials
View real-time NPM data on Freenome stock including daily Freenome stock price estimates, valuation history, and historical share price information. Access Freenome financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track Freenome pricing across six independent market signals. Looking for private company due diligence data sources on Freenome? Get in touch to learn more.
Similar Companies
like Freenome
Droplet Biosciences
Healthcare & Life Sciences
Turning surgical drain fluid into powerful, early molecular insights to guide personalized post-surgery cancer care.
Lyra
Healthcare & Life Sciences
Digital health startup using technology to connect companies and employees to mental health providers.
Hinge Health
Healthcare & Life Sciences
Digital clinic for back, joint, and muscle pain.
Eikon Therapeutics
Healthcare & Life Sciences
Uses revolutionary technology to discover novel treatments for life-threatening diseases.
Curology
Healthcare & Life Sciences
Offers personalized prescription skin care medications delivered directly to you.
Imperative Care
Healthcare & Life Sciences
Advanced medical technology solutions for stroke care.
Nomi Health
Healthcare & Life Sciences
Direct healthcare system that simplifies access to high-quality, affordable care for communities.
Heartflow
Healthcare & Life Sciences
Develops non-invasive solutions to assess significant coronary artery disease.
FAQ
We have answers
Freenome stock does not trade on public stock exchanges. Freenome stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Freenome stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Freenome Stock does not trade on public stock exchanges. In order to sell Freenome shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Freenome does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view Freenome share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for Freenome stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Freenome stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Freenome stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Freenome is a private company and has not had an IPO. There is currently no Freenome IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to Freenome IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
